Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
株式のランク #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
株価
$30.90
最終同期: 2026-08-27
時価総額
$1.90B
変化(1日)
1.68%
変化(1年)
859.63%
US
取引 Damora Therapeutics, Inc. (DMRA)

カテゴリー

Damora Therapeutics, Inc.(DMRA)の株価履歴
終値の最高値: $30.70 (2026-08-01)

終値の最安値: $375.00 (2020-10-01)
Damora Therapeutics, Inc. の株価履歴(2020 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -18.93%
2025 415.83%
2024 -67.67%
2023 -52.57%
2022 -51.37%
2021 -80.02%
2020 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$548.36 39.87%
US
$1.06K 50.29%
NL
$122.42 -11.85%
AU
$140.81 475.44%
US
$765.25 7.74%
CH